Of the test blood, 01 ml is mixed with an equal volume of an endotoxin solution. The original method (Park and Good, 1970) recommends the commercial preparations, and these will give the best results; we have found, however, that a crude filtrate of a broth culture of Escherichia coli or Pseudomonas pyocyanea will work sufficiently well. It is vital to perform the procedure in parallel on a known normal blood sample. The blood-endotoxin mixtures are incubated at 37°C for 30 minutes, and then, using 0-1 ml aliquots the direct test is performed, exactly as described earlier. The normal control will be stimulated to a level well above the normal range, ie, will rise from less than 11 to 25-30%, and the test sample is assessed against this. A temporarily suppressed neutrophil population will reveal some stimulation, though it may not be of the magnitude of the normal control, but the neutrophils in chronic granulomatous disease will remain completely unreactive.
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Comment
If the early promise of the NBT test is realized, it will quickly and justifiably become a standard test in many of our hospitals. Our concern is that it should not suffer any unjustified setbacks simply because it uses techniques which are unfamiliar to many. We hope that this guide, culled from our short experience and that of others, will help to promote an important addition to laboratory investigation. Figure 2 shows some of the ultrastructural aspects of the same giant cell after reprocessing, for example, the outer edge of the giant cell, numerous mitochondria, and some rough endoplasmic reticulum. The cytoplasmic vesicles are believed to correspond to the vacuolation visible in the thick section in Figure 1 . It is often difficult to resolve the vesicle membrane, possibly because of the sacrifice of some resolution as a result of the reprocessing. The complex folding of the giant cell outer membrane (Fig. 2) was a characteristic feature. The tangential section (Fig. 3) We were interested to read the article by Gunson, Philips, and Stratton (1972) concerning inherent errors within the automated antibody (anti-D) quantitation technique using the Technicon AutoAnalyser. However, we are unable to agree with the authors' statement that non-linearity of graphs, obtained by plotting reciprocal of dilution against optical density, is due to loss of antigen excess (antibody excess).
The following calculations are based on the conditions occurring during the reaction phase using the technique described by us (Judd and Jenkins, 1970) , and show conclusively that one is always operating with a vast excess of antigen: Assuming, (1) the molecular weight of IgG anti-D is 150 000, (2) the number of D sites per red cell (R,R1) is 20 000, a 20 % red cell suspension will contain 2 xl O" red cells/ml.
According to Avogadro's number, 1 gram molecule of any substance will contain 6 x 1023 molecules, hence 6 x 1023 molecules of anti-D will weight 150 000 grams. Therefore, 1,tg of anti-D will contain 6 x 1023 1-5 x 10 X 10s molecules ie, 4 x 1012 antibody molecules. A 20% red cell suspension will contain 2 x 109 x 20 000 D antigen sites per ml, ie, 4 x 1013 D sites per ml.
In our experience an anti-D of Iug per ml requires to be diluted 1:100 for automated assay and this dilution will, therefore, contain 4 x 1010 antibody molecules per ml.
As equal volumes of red cell suspension and serum are used in the AutoAnalyser 4 x 1010 anti-D molecules per ml will be distributed amongst 4 x 1013 D antigen sites, that is to say 1/1000th of the total number of D sites may be combined with antibody molecules assuming that all antibody is bound. In order to obtain antibody excess within the AutoAnalyzer one would require more than 4 x 1013 molecules/mI, ie, lOsg of anti-D/ml to be run through the system undiluted. If one postulates two antigen-combining sites for each antibody molecule then this figure can be halved, but at no time does one use this technique with such vast amounts of antibody.
We find a satisfactory standard graph can be obtained when operating within the range of 1:1000-1:4000 for a 20,ug/ml standard, ie, between 0 02 and 0 005 ,ug/ml. Under these conditions any nonlinearity of the graph cannot be due to antibody excess.
Our calculations show that almost complete agglutination is achieved in this system with approximately 25 antibody molecules per erythrocyte; an antibody concentration of about 0-018 ttg per ml.
Further increase in antibody concentration leads to a proportional increase in bound antibody but does not materially affect the degree of agglutination. We note these authors now quote a range for their standard graph of 0 005 to 0-02 jsg per ml whereas our comments related to their previous graph of 0 0115 to 0-115 ,cg per ml (Judd and Jenkins, 1970) .
A large antigen site excess is required to maintain sufficient erythrocytes so that the number of bound antibody molecules per erythrocyte remains small. 'Loss of antigen excess', in this context, arises when the number of bound antibody molecules per erythrocyte is such that the degree of agglutination is no longer directly proportional to anti-D concentration and does not imply excess of antibody molecules over antigen sites. 
